The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): 20m
Expected first date of trading: 19/04/2002
Market: Main
Location of address at which admission document will be available: Brewin Dolphin Securities 5 Giltspur Street London EC1A 9BD
Date at which admission document will be available: -

Advisors
Sponsor: Brewin Dolphin Securities Ltd
Nominated Advisor (AIM Companies): -
Nominated Broker (AIM Companies): -

Company details
Name Role
Dr Paul Nicholson Chairman
Mark Andrews Non-Executive Director
Charles Breese Non-Executive Director
John Randolph Hustler Non-Executive Director
Professor Alex Markham Non-Executive Director

Facts and Figures
Fiscal year end: - -
Incorporated in: England & Wales
Website URL: http://www.biosciencevet.com
space
Description of business:
A venture capital trust investing in a portfolio of companies operating in the bioscience sector managed by Octopus Asset Management Limited and Medical Marketing International plc.

Person(s) interested:
None expected.


BioScience VCT plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds